CASP3 and inflammatory bowel disease: In Vivo and in Vitro experiments demonstrate that LF provides intestinal barrier protection by restoring the tight junction (TJ) morphometry, blocking the cleavage of caspase-3, and resuming the drop in transepithelial resistance (TER) in inflammatory bowel disease (IBD) models [30,31,32].